Swan Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.34K Sell
42
-436
-91% -$38.9K ﹤0.01% 284
2026
Q1
$34.3K Buy
478
+236
+98% +$18.2K 0.01% 91
2025
Q4
$19.2K Hold
242
0.01% 126
2025
Q3
$18.2K Hold
242
0.01% 124
2025
Q2
$16.7K Sell
242
-150
-38% -$9.84K 0.01% 121
2025
Q1
$26.6K Buy
392
+150
+62% +$8.98K 0.01% 83
2024
Q4
$10.9K Hold
242
0.01% 126
2024
Q3
$15.2K Hold
242
0.01% 121
2024
Q2
$14.3K Buy
+242
New +$15.1K 0.01% 114

Other funds holding CVS

Swan Capital's CVS Position: Q2 2026 in Review

Swan Capital reduced its CVS Health (CVS) stake by 91% in Q2 2026, selling an estimated $38.9K and leaving 42 shares worth $4.34K. The position accounts for ﹤0.01% of the portfolio, ranked #284.

Swan Capital first reported a position in CVS in Q2 2024 and has held it in 9 quarters since. The position peaked at $34.3K in Q1 2026. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Swan Capital held 42 shares of CVS Health worth $4.34K as of Q2 2026.
  • Swan Capital sold 436 CVS Health shares in Q2 2026, an estimated $38.9K.
  • CVS Health made up ﹤0.01% of Swan Capital's portfolio in Q2 2026, its #284 holding.
  • Swan Capital first reported a position in CVS Health in Q2 2024 and has held it in 9 quarters since.
  • Swan Capital's CVS Health position peaked at $34.3K in Q1 2026.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.